OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
TDMS58

TDM Bhd

Healthcare Facilities & ServicesVerified

TDM Bhd maintains a debt-to-equity ratio of 0.86, indicating a moderate reliance on debt financing, while its current ratio of 1.09 suggests limited short-term liquidity cushion. The company's operating cash flow of MYR 31.99 million and free cash flow of MYR 10.17 million reflect modest cash generation, but its capital expenditure of MYR -65.31 million indicates ongoing investment in operations. Profitability metrics show a return on equity of 2.45% and return on assets of 0.96%, both below the industry median for Healthcare Facilities & Services, suggesting underperformance in capital efficiency and asset utilization. The company's operating income of MYR 72.31 million and net income of MYR 16.34 million highlight a narrow margin structure, with gross profit of MYR 272.89 million representing 35.5% of revenue. The company operates through three segments: plantations, healthcare, and investment holdings and others. The healthcare segment includes five community specialist hospitals, while the plantation segment manages 13 oil palm estates and two palm oil mills. Revenue concentration data is not disclosed, but the dual business model suggests exposure to both agricultural commodity price volatility and healthcare demand trends. TDM Bhd's revenue of MYR 768.05 million in the latest period reflects a growth trajectory that is not yet quantified in the outlook. The company's capital expenditure of MYR -65.31 million indicates ongoing investment in operations, but the free cash flow of MYR 10.17 million suggests limited capacity for shareholder returns or further expansion. The risk assessment highlights medium liquidity risk and low dilution risk, but the company's net cash position is negative after subtracting total debt, signaling potential refinancing needs. The ESG governance pillar score of 14.7 and ESG controversies score of 100.0 indicate significant governance and controversy-related risks. Recent filings and transcripts are not provided in the input data, but the company's ESG controversies score of 100.0 suggests recent or ongoing governance or operational issues that may impact stakeholder confidence.

30-day price · TDMS+0.00 (+0.0%)
Low$0.20High$0.25Close$0.22As of17 May, 00:00 UTC
Profile
CompanyTDM Bhd
TickerTDMS.KL
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. TDM Bhd operates in oil palm plantation and healthcare services, generating revenue through cultivation of oil palms, sale of fresh fruit bunches, pineapple fruit, and provision of healthcare consultancy and specialist medical center services.

Classification. TDM Bhd is classified under the Healthcare economic sector, Healthcare Services & Equipment business sector, and Healthcare Facilities & Services industry with a confidence level of 0.92.

TDM Bhd maintains a debt-to-equity ratio of 0.86, indicating a moderate reliance on debt financing, while its current ratio of 1.09 suggests limited short-term liquidity cushion. The company's operating cash flow of MYR 31.99 million and free cash flow of MYR 10.17 million reflect modest cash generation, but its capital expenditure of MYR -65.31 million indicates ongoing investment in operations. Profitability metrics show a return on equity of 2.45% and return on assets of 0.96%, both below the industry median for Healthcare Facilities & Services, suggesting underperformance in capital efficiency and asset utilization. The company's operating income of MYR 72.31 million and net income of MYR 16.34 million highlight a narrow margin structure, with gross profit of MYR 272.89 million representing 35.5% of revenue. The company operates through three segments: plantations, healthcare, and investment holdings and others. The healthcare segment includes five community specialist hospitals, while the plantation segment manages 13 oil palm estates and two palm oil mills. Revenue concentration data is not disclosed, but the dual business model suggests exposure to both agricultural commodity price volatility and healthcare demand trends. TDM Bhd's revenue of MYR 768.05 million in the latest period reflects a growth trajectory that is not yet quantified in the outlook. The company's capital expenditure of MYR -65.31 million indicates ongoing investment in operations, but the free cash flow of MYR 10.17 million suggests limited capacity for shareholder returns or further expansion. The risk assessment highlights medium liquidity risk and low dilution risk, but the company's net cash position is negative after subtracting total debt, signaling potential refinancing needs. The ESG governance pillar score of 14.7 and ESG controversies score of 100.0 indicate significant governance and controversy-related risks. Recent filings and transcripts are not provided in the input data, but the company's ESG controversies score of 100.0 suggests recent or ongoing governance or operational issues that may impact stakeholder confidence.
Key takeaways
  • TDM Bhd operates in oil palm plantation and healthcare services, with revenue of MYR 768.05 million.
  • The company's return on equity of 2.45% and return on assets of 0.96% indicate underperformance in capital efficiency.
  • The debt-to-equity ratio of 0.86 and current ratio of 1.09 suggest moderate leverage and limited liquidity.
  • The company's ESG controversies score of 100.0 and governance pillar score of 14.7 highlight significant governance and controversy-related risks.
  • TDM Bhd's capital expenditure of MYR -65.31 million indicates ongoing investment in operations.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyMYR
Revenue$768.1M
Gross profit$272.9M
Operating income$72.3M
Net income$16.3M
R&D
SG&A
D&A
SBC
Operating cash flow$32.0M
CapEx-$65.3M
Free cash flow$10.2M
Total assets$1.70B
Total liabilities$1.03B
Total equity$666.9M
Cash & equivalents
Long-term debt$573.3M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$666.9M
Net cash-$573.3M
Current ratio1.1
Debt/Equity0.9
ROA1.0%
ROE2.5%
Cash conversion2.0%
CapEx/Revenue-8.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Pharmaceuticals · cohort 25 companies
MetricTDMSActivity
Op margin9.4%18.2% medp25 18.2% · p75 24.6%bottom quartile
Net margin2.1%14.7% medp25 11.7% · p75 28.1%bottom quartile
Gross margin35.5%19.7% medp25 19.7% · p75 39.8%above median
R&D / revenue24.3% medp25 6.6% · p75 24.3%
CapEx / revenue-8.5%4.9% medp25 4.2% · p75 6.3%bottom quartile
Debt / equity86.0%71.3% medp25 19.0% · p75 91.7%above median
Observations
IR observations
market data ESG controversies score100.0
market data ESG governance pillar14.7
market data ESG social pillar73.4
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 09:37 UTC#57645ac8
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 09:40 UTCJob: cbcee516